#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12840	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2153	587.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1654	1654	T	661	T,C	638,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12840	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2153	587.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1388	1388	C	742	C	723	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24224	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3528	679.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1678	1678	A	807	A,G	769,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24224	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3528	679.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2312	2312	C	716	C,A	686,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24224	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3528	679.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2386	2386	A	704	A,G	681,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24224	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3528	679.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2938	2938	C	732	C,G	710,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24224	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3528	679.5	0	HET	.	.	.	C1161T	.	1161	1161	C	1502	1502	C	779	C,T	572,181	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1614	folP	855	855	100.0	folP.l6.c4.ctg.1	1520	104.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1085	1087	AGC	163;162;164	A;G;C	163;161;161	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4150	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3436	119.8	1	SNP	p	S91F	1	.	.	271	273	TTC	615	617	TTC	120;119;121	T;T;C	117;116;116	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4150	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3436	119.8	1	SNP	p	D95G	1	.	.	283	285	GGC	627	629	GGC	123;125;125	G;G,C;C	119;118,1;119	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4150	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3436	119.8	1	SNP	p	G95N	0	.	.	283	285	GGC	627	629	GGC	123;125;125	G;G,C;C	119;118,1;119	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1452	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1324	108.4	1	SNP	p	G45D	0	.	.	133	135	GGC	435	437	GGC	171;172;173	G;G;C	161;161;163	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	720	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	926	76.7	0	.	n	.	0	A197.	DEL	197	197	A	556	556	A	163	A	156	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3852	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3056	124.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1598	1600	GTC	150;149;148	G,A;T;C	146,1;139;143	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3852	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3056	124.9	1	SNP	p	D86N	0	.	.	256	258	GAC	704	706	GAC	142;140;138	G;A;C	137;133;135	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3852	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3056	124.9	1	SNP	p	R87W	0	.	.	259	261	CGT	707	709	CGT	138;137;139	C;G;T	136;133;133	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3852	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3056	124.9	1	SNP	p	S87R	1	.	.	259	261	CGT	707	709	CGT	138;137;139	C;G;T	136;133;133	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3852	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3056	124.9	1	SNP	p	R87I	0	.	.	259	261	CGT	707	709	CGT	138;137;139	C;G;T	136;133;133	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3852	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3056	124.9	1	SNP	p	S88P	0	.	.	262	264	TCC	710	712	TCC	138;141;140	T;C;C	134;136;136	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3490	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2624	131.8	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1302	1304	TGC	161;157;156	T;G;C	156;148;149	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3490	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2624	131.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	188;185;182	G;G;C	176;174;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1152	1154	GCA	182;186;190	G;C;A	173;175;183	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1155	1157	ATC	192;193;193	A,T;T;C	181,1;185;184	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1167	1169	GTG	192;192;194	G;T,G;G	183;181,1;185	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1167	1169	GTG	192;192;194	G;T,G;G	183;181,1;185	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1671	1673	ACC	182;183;183	A;C;C	165;175;174	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1725	1727	GCG	143;137;135	G;C;G	129;113;124	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1725	1727	GCG	143;137;135	G;C;G	129;113;124	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1848	1850	GGC	129;128;128	G;G;C	123;121;119	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1857	1859	GGC	123;123;123	G;G;C	115;115;113	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3446	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2258	150.4	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1875	1877	TCG	124;127;127	T,G;C,G;GCCC,GCCCC	81,9;105,1;97,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5090	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3026	166.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1525	1527	CCG	186;185;188	C;C;G	174;175;174	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2000	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1864	105.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	566	566	C	129	C	125	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	503	505	GAA	228;224;225	G;A;A	223;219;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	791	793	GAT	199;198;202	G,A;A;T	193,2;192;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	914	916	TCA	223;221;219	T,C;C;A	213,1;213;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	0	.	p	.	0	F215S	NONSYN	643	645	TTT	1034	1036	TCT	177;176;174	T,C;C,T;T	166,1;167,1;170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1043	1045	GTC	184;183;186	G,A;T;C	179,1;176;181	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1373	1375	GCA	179;181;183	G;C,A;A	174;171,2;177	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	1	SNP	p	G120K	1	.	.	358	360	AAG	749	751	AAG	213;208;211	A;A;G	203;200;202	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	1	SNP	p	A121D	1	.	.	361	363	GAC	752	754	GAC	209;206;208	G,A;A,G;C	198,3;197,1;200	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2554	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1582	160.3	1	SNP	p	D121N	0	.	.	361	363	GAC	752	754	GAC	209;206;208	G,A;A,G;C	198,3;197,1;200	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9368	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4796	193.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2037	2039	AAT	214;214;216	A,C;A;T	206,3;208;207	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1024	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1027	97.8	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	217;215;213	A;T;G	209;207;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
